                </a></li></ul></div><p><strong>Figure 4.  <span>Identifying selectable surface antigens for the isolation of putative RoSH-like cells from differentiating ESCs.</span></strong></p><a id="article1.body1.sec3.sec3.fig2.caption1.p1" name="article1.body1.sec3.sec3.fig2.caption1.p1"></a><p>a) Confocal microscopy of E-RoSH2.1 cells <em>(top)</em> and E14 ESCs <em>(bottom)</em>.</p>
<a id="article1.body1.sec3.sec3.fig2.caption1.p2" name="article1.body1.sec3.sec3.fig2.caption1.p2"></a><p>The cells were counterstained with DAPI, a nuclear stain after immunostaining for anti-SSE4-1 antibody conjugated with FITC and anti-CD9 antibody conjugated with PE.</p>
<a id="article1.body1.sec3.sec3.fig2.caption1.p3" name="article1.body1.sec3.sec3.fig2.caption1.p3"></a><p>b) FACS analysis of i) E-RoSH2.1 cells, ii) E14 ESCs, iii) murine embryonic fibroblast (MEF) and iv) 10:1 mixture of E14 ESCs and E-RoSH2.1 cells.</p>
<a id="article1.body1.sec3.sec3.fig2.caption1.p4" name="article1.body1.sec3.sec3.fig2.caption1.p4"></a><p>The cells were labelled with anti-CD9 antibody conjugated with PE and anti-SSE4-1 antibody conjugated with FITC, and analyzed on a FACS Aria using FACS Diva software (BD Biosciences Pharmingen, San Diego, CA).</p>
